ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2026
Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES).
Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To understand the effects of removing race from fracture calculators, we analyzed the changes in osteoporosis treatment eligibility between race-specific and race-neutral FRAX in NHANES. Overall, we found small changes in treatment eligibility (< 5%) with slight increases among Black, Hispanic, and Asian participants and a slight decrease among White participants. PURPOSE: The Fracture Risk Assessment Tool (FRAX) calculates the 10-year risk of major osteoporotic fracture (MOF) and hip fracture. In the USA, the calculator adjusts the probability down by 0.43-0.64 in Black, Hispanic, and Asian people based on historical data. Recently, an ASBMR Taskforce recommended the creation of a population-based, race-neutral calculator. The effects of this recommendation on treatment eligibility are not clear, so this study sought to quantify changes in treatment eligibility in the National Health and Nutrition Examination Survey (NHANES).
methodsWe analyzed participants in NHANES 2013-2014 and 2005-2010 and calculated the current FRAX based on questionnaires and bone mineral density (BMD). We then calculated a separate race-neutral FRAX using census data and compared treatment eligibility between the two calculators based on thresholds of 20% for MOF or 3% for hip fracture. We also examined treatment eligibility based on either clinical criteria (BMD T-score ≤ -2.5 or prior hip or vertebral fracture) or FRAX eligibility.
resultsAmong 3035 and 8458 participants in NHANES 2013-2014 and 2005-2010, we found small absolute changes to treatment eligibility. In NHANES 2013-2014, the percent eligible using race-neutral FRAX decreased from 18.4 to 14.9% for White women and increased from 1.9 to 5.2% for Black women, from 3.9 to 7.0% for Hispanic women, and from 9.3 to 12.6% for Asian women. Changes in men were even smaller.
conclusionWe found that changing US FRAX to a race-neutral calculator would only modestly increase treatment eligibility in US Black, Hispanic, and Asian people, while slightly decreasing eligibility in White people.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.